FIGURE 1.

(A) Schematic illustration of the procedure for the generation of NV and chemotherapeutics-loaded NV (Jang et al., 2014). (B) Schematic process of nanovesicle generation (Jo et al., 2014). (C) Schematic illustration of the procedure for generation of ghost nanovesicles (ghost NVs) and dexamethasone-loaded ghost NVs (Go et al., 2019). (D) Schematic shows a process to generate a uniform size of nanovesicles including cell disruption, differential centrifugation, and extrusion (Gao et al., 2016). (E) Production and drug loading of NIbS derived from cancer cells and efficient therapeutic efficacy against murine EL4 tumors by EL4-derived NIbS/DOX (Ingato et al., 2018).